Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Clinical trial NCT06909565 · RECRUITING
Trial details
- NCT number
- NCT06909565
- Sponsor
- Duke University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-23
- Primary completion
- 2029-10-01
- Enrollment
- 6000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.